Purchases and Sales Made in Q2 2022 in Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL) during Q2 2022. The information is specifically focused on institutions that hold shares of Autolus Therapeutics plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-111K- 84.03% |
$226K - $518K
|
21K
$62.9K
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-173K- 21.64% |
$353K - $810K
|
627K
$1.87M
|
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-354K- 94.4% |
$723K - $1.66M
|
21K
$62.9K
|
|
|
Aug 15, 2022
Q2 2022
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-372KClosed |
$758K - $1.74M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-383KClosed |
$780K - $1.79M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-436K- 41.07% |
$889K - $2.04M
|
625K
$1.87M
|
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.36M- 38.69% |
$2.77M - $6.36M
|
2.15M
$6.44M
|